摘要
目的:探讨丹参、通心络胶囊治疗冠心病的临床疗效及安全性。方法:58例冠心病患者随机分为治疗组和对照组,对照组静滴硝酸甘油,治疗组静滴复方丹参,口服通心络胶囊,观察临床症状,心电图,血液流变学等变化。结果:两组临床症状,心电图无显著差异性(P>0.05),4周内进展为急性心肌梗塞对照组3例(10.71%),治疗组无发生,有统计学意义(P=0.0455),血液流变学有显著差异性(P<0.01或P<0.05)。结论:丹参、通心络胶囊联用无副作用,作用相加,具有扩张冠脉,降低血液粘度,抑制血小板等,改善临床症状,是治疗冠心病有效药物。
Objective： To discuss the clinical curative effect and safety of coronary heart disease who were treated with root of red - rooted salvia coadunited Tongxinluo capsules. Methods： We trabant dieretic 58 cases into therapeusis group and control group, the control group were infusion by intravenous drip nitroglycerin , the other were root of red - rooted salvia injection, oral Tongxinluo capsules, and then observed the clinical symptoms, the alleosis of electrocardiogram and hemorrheology. Results： Both of the groups have no difference significant on clinical symptoms and electrocardiogram （ P 〉 0.05 ）, 4 weeks later, 3 cases were strided acute myocardial infarction in control group（ 10.71%）, the other didn＇t generate. It has statistical sense （ P = 0.0455 ）, and significant difference on hemorrheology （ P 〈 0.01 or P 〈 0.05 ）. Conclusion： It has no side effect if we treated with root of red - rooted salvia coadunited Tongxinluo capsules, both of them can distente coronary artery, debase the blood viscosity, inhibite thrombocyte, improve the clinical symptoms, they are useful for coronary heart disease treatment.
出处
《河北医学》
CAS
2006年第1期51-52,共2页
Hebei Medicine
关键词
冠心病
丹参
通心络胶囊
Coronary heart disease
Root of red -rooted salvia
Tongxinluo capsule
